I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| ciliated cell | 10 studies | 27% ± 8% | |
| non-classical monocyte | 8 studies | 36% ± 21% | |
| classical monocyte | 7 studies | 33% ± 16% | |
| endothelial cell | 6 studies | 20% ± 4% | |
| fibroblast | 6 studies | 30% ± 18% | |
| astrocyte | 6 studies | 25% ± 9% | |
| basal cell | 5 studies | 24% ± 7% | |
| smooth muscle cell | 5 studies | 17% ± 1% | |
| plasmacytoid dendritic cell | 5 studies | 20% ± 3% | |
| myeloid cell | 4 studies | 27% ± 10% | |
| type I pneumocyte | 4 studies | 22% ± 5% | |
| ionocyte | 3 studies | 45% ± 5% | |
| respiratory goblet cell | 3 studies | 26% ± 4% | |
| secretory cell | 3 studies | 29% ± 5% | |
| squamous epithelial cell | 3 studies | 51% ± 15% | |
| B cell | 3 studies | 20% ± 3% | |
| CD16-positive, CD56-dim natural killer cell, human | 3 studies | 19% ± 3% | |
| conventional dendritic cell | 3 studies | 39% ± 20% | |
| epithelial cell | 3 studies | 42% ± 11% | |
| macrophage | 3 studies | 16% ± 1% | |
| monocyte | 3 studies | 20% ± 3% | |
| rod bipolar cell | 3 studies | 35% ± 9% | |
| dendritic cell | 3 studies | 39% ± 31% | |
| oligodendrocyte precursor cell | 3 studies | 23% ± 5% |
